What is the relationship between MASLD and NAFLD?
NAFLD is a term that was used focusing on liver fat accumulation not caused by heavy drinking. Recently, the term MASLD is used to more clearly express the connection with metabolic risk. The NIDDK also explains both terms together in its existing guidelines.
Even if the terminology changes, it is important to distinguish between a state of having only liver fat and a state accompanied by inflammation, cell damage, and fibrosis.
Why does it occur?
insulin resistanceand abdominal fat, type 2 diabetesand dyslipidemiaare commonly associated. The values seen on body composition analyzers Visceral fat levelare not values that directly measure liver fat. Genetic predisposition, diet, activity, and medications also play a role. It can occur even in people with a lean body type.
Alcohol consumption, viral hepatitis, and other medication or metabolic causes must be checked together.
Can it be detected through symptoms and liver enzyme levels?
Most people have no specific symptoms, while some experience fatigue and discomfort in the upper right abdomen. Since fatty liver and fibrosis can exist even if ALT and AST are normal, they are not ruled out by these levels alone.
Ultrasound can detect fat accumulation, but it cannot definitively confirm both inflammation and early fibrosis.
What is evaluated?
Body weight and waist circumference, blood glucose, lipids, blood pressure, and alcohol intake are checked. Fibrosis risk scores may be calculated through blood tests such as liver enzymes and platelets, or elasticity tests and imaging may be required.
If the risk of fibrosis is high or if levels remain abnormal, a professional liver evaluation is conducted.
How is weight managed?
Maintain a calorie-controlled diet including vegetables, whole grains, appropriate protein, and unsaturated fats, along with regular physical activity. Reduce sugary drinks and excessive alcohol consumption.
Rapid fasting or unverified supplementation methods can place a burden on the liver. Inform your medical staff of all medications, Korean herbal medicine, and supplements you are taking.
What is the difference between fatty liver, steatohepatitis, and fibrosis?
The mere presence of fat accumulation in the liver does not reveal the extent of inflammation or scarring. In some cases, liver cell damage and inflammation occur, which can progress to fibrosis over time. When assessing health risks, the stage of fibrosis may be more important than the amount of fat.
Not everyone who is told they have 'fatty liver' on an ultrasound is at the same stage. Conversely, even if an ultrasound appears mild, the possibility of fibrosis may be evaluated separately if risk factors such as diabetes or obesity are present.
Is it okay if my liver levels are normal?
Even if ALT and AST are within the normal range, fatty liver or advanced fibrosis cannot be completely ruled out. Liver function testsThis is because these terms refer to a group of items, and liver enzymes are signals of damage at the time of blood collection, not a test that directly measures the amount of fat and scarring in the liver.
Test values are reviewed alongside gender, laboratory standards, and trends over time. If there are persistent abnormalities or risk factors, the medical staff will select the necessary evaluation among scores combining blood tests, elasticity tests, or imaging tests.
Does the name change if I drink less alcohol?
MASLD is the current term defined primarily by metabolic risk factors and liver fat. If alcohol consumption is added, a separate category may be considered. Actual alcohol intake should be verified using the type, volume, and alcohol percentage rather than the number of glasses.
Being diagnosed with metabolic fatty liver does not mean the influence of alcohol disappears. Please be honest about your weekly alcohol intake and binge drinking patterns to consult on alcohol consumption standards tailored to your individual liver condition.
What is compared during follow-up?
Weight, waist circumference, blood pressure, blood glucose, lipids, ALT, AST, and platelets are organized by date, and results from imaging and elasticity tests are kept together. Marking the start date of medications and supplements, as well as changes in alcohol consumption, helps in interpreting changes in the values.
The goal is sustainable weight loss and improvement of metabolic indicators rather than rapid weight loss over a short period. Do not arbitrarily stop fibrosis follow-ups just because one liver level has improved; follow the scheduled intervals.
The degree of fatty liver and the risk of liver damage are not the same thing
MASLD describes liver fat accumulation related to metabolic risk, but the degree of fatty liver seen on an ultrasound alone cannot determine the stage of inflammation and fibrosis. Fat accumulation or fibrosis can exist even if liver levels are normal; conversely, elevated liver levels can be caused by other factors such as medication, viruses, or alcohol.
Fibrosis scores using blood tests and age are risk screening tools, not confirmatory tests. Based on the results, it is determined whether an elasticity test or professional evaluation is necessary.
Weight management considers both the liver and muscles
Rather than rapid weight loss, we plan for sustainable energy regulation, aerobic and strength activities, and a reduction in alcohol and sugary drinks. While monitoring trends in weight, waist circumference, liver levels, blood glucose, and lipids, we also check that muscle strength and nutritional status do not decline.
If you experience jaundice, dark urine, abdominal bloating, changes in consciousness, or a tendency to bleed, do not simply monitor it through lifestyle management. You must inform the medical staff of all substances being taken, including supplements and Korean herbal medicine, to establish a plan appropriate for the stage of liver disease.
What is the sequence of verification after discovering fatty liver?
First, we organize whether fat accumulation was seen on imaging, when liver enzymes began to change, and your alcohol intake and medications. Next, we check metabolic risks such as weight, waist circumference, blood pressure, blood glucose, and lipids. Other causes such as viral hepatitis and medications must be excluded so that the situation is not oversimplified as being 'due to weight'.
The next step is screening for fibrosis risk. Scores combining blood tests are tools to determine the need for additional testing and are not a confirmation in themselves. Since interpretation can vary based on age and testing conditions, do not feel reassured or conclude you have liver cirrhosis based solely on internet calculator results.
What does it mean when follow-up results have improved?
We look for simultaneous improvements in weight, waist circumference, blood glucose, lipids, and liver enzymes. Even if liver enzymes decrease, the risk of fibrosis does not automatically disappear, and metabolic risk management must continue even if the degree of fat on imaging decreases. Conversely, even if weight change is small, the process of improving activity, diet, blood glucose, and lipids is meaningful.
The interval and goals for testing vary depending on the initial fibrosis risk, the presence of diabetes or obesity, and the treatment details. If comparing results from multiple institutions, keep the test dates, fasting status, and reference ranges together. Prioritize trends under the same conditions and the assigned medical plan over a single numerical value.
Before starting diet pills, Korean herbal medicine, or supplements
It is recommended to show the ingredient list, prescription, dosage, and start date rather than just stating the names of the items you are taking. Taking multiple types together makes it difficult to distinguish the cause of symptoms, and advertisements claiming something is 'good for the liver' do not guarantee effectiveness in treating fatty liver or ensure liver safety. We do not test levels by removing existing medications or adding new substances.
If new changes occur after intake, such as severe fatigue, loss of appetite, nausea, jaundice, or dark urine, notify the prescribing medical institution before continuing the next dose. Urgent conditions such as changes in consciousness, severe bleeding, or difficulty breathing require immediate emergency evaluation.
Related Terms
Metabolic dysfunction-associated steatotic liver disease (MASLD): It is clearer when viewed with these terms
Metabolic syndrome is a condition where risk factors such as abdominal obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol appear together in one person. When these factors overlap, the risk of cardiovascular disease and type 2 diabetes increases.
→ Metabolism & Hormones Insulin resistanceInsulin resistance is a condition where muscle, fat, and liver cells do not respond sufficiently to insulin signals. The pancreas may compensate by producing more insulin, but over time, if blood sugar levels rise, it can lead to prediabetes or type 2 diabetes.
→ Body Composition · Measurement Visceral fatVisceral fat is fat that accumulates around the organs within the abdominal cavity. Its location differs from subcutaneous fat under the skin and is more closely related to the risk of metabolic abnormalities, but the visceral fat grade on home body composition devices is not a direct imaging measurement.
→ Comorbidities · Tests ObesityObesity is a chronic and recurrent disease characterized by the excessive accumulation of body fat to an extent that it can affect health. For adults in Korea, BMI and waist circumference are used as basic indicators, but comorbidities, body composition, and living environment are also evaluated.
→ Comorbidities · Tests PrediabetesPrediabetes is a state where blood sugar levels are higher than the normal range but have not yet reached the diagnostic criteria for diabetes. It is often asymptomatic and is confirmed through fasting blood glucose, HbA1c, or an oral glucose tolerance test.
→Questions
Frequently Asked Questions about MASLD
Can fatty liver occur even if I do not drink alcohol?
Yes, it is possible. Insulin resistance, obesity, type 2 diabetes, blood lipids, and genetic factors may be involved. Alcohol consumption levels should also be checked separately.
If my liver levels are normal, does that mean I do not have fatty liver?
Fatty liver can be present even if liver enzyme levels are normal. We evaluate risk factors and imaging, and perform fibrosis assessment if necessary.
Will it improve if I lose weight?
If overweight, sustainable weight loss can help improve liver fat and metabolic risks. Avoid excessively rapid weight loss and nutritional imbalances.
Is this a disease caused by eating fat?
It is not a disease caused by dietary fat alone. Total energy intake, sugars and refined carbohydrates, physical activity, genetics, and metabolic status are all involved.
Medical professional who reviewed this text
Choi Yeon-seung
Chief Director of Baekrokdam Korean Medicine ClinicWe have reviewed the term MASLD and the former NAFLD designation, asymptomatic cases and liver level limitations, fibrosis risk, and weight and metabolic management. During medical evaluation, we check actual symptoms, diet, sleep, and activity in addition to numerical values.
- Graduated from Kyung Hee University College of Korean Medicine
- Practicing Korean medicine since 2010
- Specializing in constitution improvement and weight loss herbal medicine
- Content Authoring
- Baekrokdam Korean Medicine Clinic
- Content Reviewed by
- Dr. Choi Yeon-seung, KMD
- Review Scope
- MASLD and the former NAFLD designation, asymptomatic cases and liver level limitations, fibrosis risk, and weight and metabolic management
- Last Reviewed
- August 23, 2026
This page provides general health information and does not replace individual diagnosis or prescription.
Source
Supporting Evidence
- Definition and Facts of NAFLD and NASH ↗ National Institute of Diabetes and Digestive and Kidney Diseases
- Health Risks of Overweight and Obesity ↗ National Institute of Diabetes and Digestive and Kidney Diseases
- Obesity ↗ Korea Disease Control and Prevention Agency National Health Information Portal